Missing/wrong data?
Log in to edit
First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD study
scientific article published on 10 January 2012
Author/s
author: Eduardo Díaz-Rubio, Adelaida Lacasta, Josep Tabernero Caturla
Work details
Publication date
January 10, 2012
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.